Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.

Georgia Fogden-King's Articles

Sciad Communications Announces Corporate Sponsorship of OBN

Sciad Newswire / Sciad Communications, the science, tech and health communications consultancy, is pleased to announce its corporate sponsorship of OBN, the membership organisation supporting the UK’s innovative life sciences companies.

Novo Nordisk’s semaglutide spurs major weight loss in phase 2 obesity study

Novo Nordisk’s closely watched semaglutide has already shown it can spur weight loss in diabetic patients. Now it’s added evidence that it can help nondiabetic obesity patients shed pounds, too.

Oxford Nanopore Technologies Raises £100M in Funding

UK-based developer of a portable real-time DNA/RNA sequencer, raised £100M ($140M) in new funding.

Fuel3D to establish new headquarters on The Oxford Science Park

Company to be first occupier of the Park’s state-of-the-art Schrödinger Building

Celebrating two years in business!

Arcinova was launched in February 2016, following the acquisition of the Covance site in Alnwick, by Arc Trinova Limited, a new company formed by Ian Shott and Paul Ryan, owners of Shott Trinova LLP.

Oxford 3D bioprinting company OxSyBio secures £10m in funding

OxSyBio, an Oxford University biotech spinout company developing 3D printer technology capable of printing biological materials with a diverse range of therapeutic purposes, has secured £10m in Series A financing from Woodford Investment Management alongside new and existing backers.

Immunotherapy Used to Treat Aggressive Colon Tumors

Acquisition establishes an Asia Pacific Headquarters for PCI


Prokarium secures $10 million investment from Saudi, Swedish and Korean investors for clinical development of revolutionary thermostable vaccines

Prokarium, the UK-based synthetic biology company that has developed Vaxonella, an oral, thermostable vaccine delivery platform, today announced the completion of a $10 million investment round.

High Throughput PARP Screening Assay

AMSBIO is a specialist life science company offering an extensive portfolio of Poly (ADP-ribose) polymerase (PARP) isozymes.  In addition, AMSBIO also offer assay kits, inhibitors, recombinant histone substrates and screening / profiling services for over 10 different PARP’s.

Congenica Signs Strategic Digital Health Contracts During Official UK-China Trade Mission

Collaborations and commercial contracts to advance company’s growth and role in Asia

Pages: Previous1234567...12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us,, and we will post.